We can guide you through every step of your weight loss journey, providing tailored diet and exercise plans
In a meta-analysis of major RCTs, GLP-1RAs reduced composite major CV events by 14% (hazard ratio [HR], 0.86
Glossary CLBP chronic low back pain CKD chronic kidney disease CNS central nervous system CV cardiovascular CVD cardiovascular disease FDA Food and Drug Administration GLP-1 glucagon-like peptide-1 GLP-1s glucagon-like peptide-1 receptor agonists HF heart failure HTN hypertension MACE major adverse cardiovascular events MASH metabolic dysfunction-associated steatohepatitis OA osteoarthritis OSA obstructive sleep apnea PAD peripheral arterial disease SC subcutaneous SGLT2i sodium-glucose co-transporter 2 inhibitor sNDA supplemental New Drug Application T1DM type 1 diabetes mellitus T2DM type 2 diabetes mellitus U.S
Semaglutide is the name on everybody's lips these days, as a stunningly effective treatment for type 2 diabetes and as a surprisingly effective and low side-effect weight loss medication
Remember, before making any changes to your diet or starting a new supplement regimen, its always a good idea to consult with a healthcare professional to ensure it aligns with your specific needs and medical history
Paul Kolodzik returns to The AGEIST Podcast to discuss his pioneering work around GLP-1s: using these medications to help people reduce their alcohol intake